Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omeprazole plus mosapride vs omeprazole in PPI-refractory GERD
TCTR20190418003Phase 4Completed
- Sponsor
- Rajavithi Hospital
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of omeprazole, mosapride in gastroesophageal reflux disease (GERD), sponsored by Rajavithi Hospital. Started Jan 2016; status: completed.
02
Drugs
omeprazolemosapride
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on TCTR20190418003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190418003.